Could a common diabetes pill strengthen the failing right heart in PAH patients?
Disease control
ENROLLING_BY_INVITATION
This study tests whether empagliflozin, a drug already used for diabetes, can improve right heart function in 78 adults with pulmonary arterial hypertension (PAH). Participants continue their usual PAH medications and are randomly assigned to receive either empagliflozin or a pla…
Phase: PHASE2 • Sponsor: Gustavo A Heresi, MD, MS • Aim: Disease control
Last updated May 26, 2026 12:10 UTC